LOGC
State Street’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-33,907
| Closed | -$9K | – | 4960 |
|
2022
Q3 | $9K | Hold |
33,907
| – | – | ﹤0.01% | 4898 |
|
2022
Q2 | $12K | Hold |
33,907
| – | – | ﹤0.01% | 4918 |
|
2022
Q1 | $23K | Hold |
33,907
| – | – | ﹤0.01% | 4876 |
|
2021
Q4 | $78K | Hold |
33,907
| – | – | ﹤0.01% | 4625 |
|
2021
Q3 | $155K | Buy |
33,907
+9,100
| +37% | +$41.6K | ﹤0.01% | 4439 |
|
2021
Q2 | $110K | Sell |
24,807
-208,732
| -89% | -$926K | ﹤0.01% | 4342 |
|
2021
Q1 | $1.7M | Buy |
233,539
+18,781
| +9% | +$137K | ﹤0.01% | 3499 |
|
2020
Q4 | $1.64M | Buy |
214,758
+57,093
| +36% | +$436K | ﹤0.01% | 3435 |
|
2020
Q3 | $1.43M | Sell |
157,665
-420
| -0.3% | -$3.82K | ﹤0.01% | 3326 |
|
2020
Q2 | $1.34M | Buy |
158,085
+30,845
| +24% | +$261K | ﹤0.01% | 3329 |
|
2020
Q1 | $629K | Sell |
127,240
-208
| -0.2% | -$1.03K | ﹤0.01% | 3402 |
|
2019
Q4 | $918K | Buy |
127,448
+8,175
| +7% | +$58.9K | ﹤0.01% | 3424 |
|
2019
Q3 | $1.29M | Sell |
119,273
-652
| -0.5% | -$7.05K | ﹤0.01% | 3347 |
|
2019
Q2 | $1.56M | Buy |
119,925
+51,478
| +75% | +$669K | ﹤0.01% | 3329 |
|
2019
Q1 | $676K | Buy |
68,447
+8,329
| +14% | +$82.3K | ﹤0.01% | 3404 |
|
2018
Q4 | $625K | Buy |
+60,118
| New | +$625K | ﹤0.01% | 3414 |
|